OTCM
RNVA
Market cap43kUSD
Oct 08, Last price
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
-100.00%
Name
Rennova Health Inc
Chart & performance
P/E
—
P/S
0.00
EPS
—
Div yield, %
—
Shrs. gr., 5y
7,926.17%
Rev. gr., 5y
23.06%
Revenues
19m
+43.34%
Net income
-8m
L+134.71%
CFO
3m
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Rennova Health, Inc., through its various subsidiaries, provides medical services throughout the United States. As of December 31, 2021, the company's assets included an operational hospital situated in Oneida, Tennessee; an acute care facility and an associated doctor's practice located in Jamestown, Tennessee; and a rural medical clinic in Williamsburg, Kentucky. The organization was founded in 2005 and has its principal office in West Palm Beach, Florida.
Key people
Chairman of the Board · since 2015
Seamus Lagan
President, Interim Chief Financial Officer · since 2019
John B. Beach
Director · since 2017
Director · since 2014
Christopher E. Diamantis
Director · since 2015
Robert P. Lee
Director · since 2015
Gary L. Blum
Independent Director · since 2017
Legal address
C/O CORPORATION SERVICE COMPANY
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
44 Montgomery Street
Suite 800
San Francisco, CA 94104
US
Suite 800
San Francisco, CA 94104
US
Previous name
CollabRx, Inc.
Previous name
Tegal Corp
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||